Piramal Of India Acquires RxElite Holdings Of U.S.
This article was originally published in PharmAsia News
Executive Summary
India's Piramal Healthcare has paid $4.2 million to acquire U.S.-based RxElite Holdings. The merger gives the Indian company greater sales and distribution strength in the U.S. market for its recently acquired Minrad International along with its inhalation anesthetic gas. RxElite Holdings is a subsidiary of RxElite, also U.S.-based, which supplies hospitals, wholesalers and surgery facilities. (Click here for more